Novel identified micropeptide LEAO reshapes plasticity of adipose tissue to improve metabolic homeostasis
Journal of Endocrinological Investigation · 2026
DOI: 10.1007/s40618-026-02813-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2026. Verfasst von Siqi Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Sun Yat- Sen Un…. Hauptthemen laut MEDLINE: Homeostasis, Obesity, Adipose Tissue, RNA, Long Noncoding. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Shenzhen Science and Technology Project, Fund of Shenzhen Key Laboratory.
Abstract (Originalsprache)
Adipose tissue exhibits remarkable plasticity, defined as its capability of adapting to various environments and energy demands by undergoing shifts in phenotypic, metabolic characteristics, and structure. However, obesity often results in diminished adipose tissue plasticity. Long non-coding RNA (lncRNA) is a class of RNA defined as being more than 200 nucleotides long and lacking protein-coding capability. With advancements in ribosome profiling, mass spectrometry, and other research technologies, an increasing number of studies have confirmed that short open reading frames (less than 300 nucleotides) within lncRNAs have the capacity to encode functional micropeptides. In our study, we initially identified a biologically active micropeptide, lncRNA Esrp2-as-ORF1(LEAO), encoded by lncRNA Esrp2-as in mice. In diet-induced obesity (DIO)mice, this micropeptide demonstrates the ability to induce fat browning, enhance adipose tissue plasticity, and subsequently improve metabolic homeostasis. Additionally, we observed that the micropeptide LEAO exerts its effects on adipocytes by stimulating IL6 secretion in adipose tissue macrophages. In summary, LEAO may have therapeutic potential for obesity-related metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Sun Yat- Sen University, Shenzhen, 518107, Guangdong Province, China.
- Department of Oncology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, Guangdong Province, China. sunshine1d1@126.com.
- Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Sun Yat- Sen University, Shenzhen, 518107, Guangdong Province, China. yangzhh@mail.sy…
Förderung
- Shenzhen Science and Technology Project
- Fund of Shenzhen Key Laboratory
Zitieren
APA
Liu, S., Song, B., Hu, L., Zhao, Z., Li, J., Li, X., Qian, B., Cai, Y., Lin, J., Wu, Q., Sun, X., & Yang, Z. (2026). Novel identified micropeptide LEAO reshapes plasticity of adipose tissue to improve metabolic homeostasis. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-026-02813-7
Vancouver
Liu S, Song B, Hu L, Zhao Z, Li J, Li X, et al. Novel identified micropeptide LEAO reshapes plasticity of adipose tissue to improve metabolic homeostasis. Journal of Endocrinological Investigation. 2026. doi:10.1007/s40618-026-02813-7
BibTeX
@article{Liu2026,
author = {Liu, Siqi and Song, Bigui and Hu, Longyun and Zhao, Zewei and Li, Jin and Li, Xiaoxiao and Qian, Bingxiu and Cai, Yi and Lin, Jiejing and Wu, Qian and Sun, Xian and Yang, Zhonghan},
title = {Novel identified micropeptide LEAO reshapes plasticity of adipose tissue to improve metabolic homeostasis},
journal = {Journal of Endocrinological Investigation},
year = {2026},
doi = {10.1007/s40618-026-02813-7}
}
EUVIMED